Cargando…
FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation
BACKGROUND: Increasing evidence suggests that FBXW7 has a high frequency of mutations in esophageal squamous cell carcinoma (ESCC). However, the function of FBXW7, especially the mutations, is not clear. This study was designed to investigate the functional significance of FBXW7 loss of function and...
Autores principales: | Pan, Yunzhi, Liu, Jing, Gao, Yingyin, Guo, Yuqing, Wang, Changxing, Liang, Zhipan, Wu, Meiying, Qian, Yulan, Li, Yinyan, Shen, Jingyi, Lu, Chenchen, Ma, Sai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054043/ https://www.ncbi.nlm.nih.gov/pubmed/36991467 http://dx.doi.org/10.1186/s13046-023-02630-3 |
Ejemplares similares
-
[Retracted] miR‑25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma
por: Hua, Ye, et al.
Publicado: (2023) -
FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells
por: An, Hyun-Jung, et al.
Publicado: (2022) -
TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
por: Shi, Hui, et al.
Publicado: (2021) -
FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma
por: Qiu, Bo, et al.
Publicado: (2023) -
Clinical significance of FBXW7 loss of function in human cancers
por: Fan, Jingyi, et al.
Publicado: (2022)